H NMR (400 MHz
calcd. for [M+TFA] + , 281.3 calcd. for [M] 2+ , 243.3 calcd. for [M-aminopropyl] 2+ . 3 All the ruthenium complexes were obtained as trifluoroacetic salts, as TFA is used for purifications. 
Bromoacetyl bromide (20.5 mg, 0.101 mmol) was added to a solution of 1a (38 mg, 0.048 mmol), Et 3 N (19.5 mg, 0.192 mmol) in 0.5 ml of DMF. After stirring for 1 h at room temperature, the crude was diluted in water (1:5) and purified by semipreparative RP-HPLC (gradient: 5% B 5 min, 5% to 50 % B 40 min). The combined fractions were concentrated and freeze-dried to obtain the desired product 2 as a brown trifluoroacetic salt (28 mg, 0.028 mmol, 58% yield). 
Peptide Synthesis
C-terminal amide peptides were synthesized following standard peptide protocols (Fmoc/tBu strategy) on a 0.1 mmol scale using a 0.19 mmol/g loading Fmoc-PAL-PEG-PS resin from Applied Biosystems, using a PS3 automatic peptide synthesizer from Protein Tecnologies. The amino acids were coupled in 4-fold excess using HBTU as activating agent. Each amino acid was activated for 30 seconds in DMF before being added onto the resin, and couplings were conducted for 30 min. Deprotection of the temporal Fmoc protecting group was performed by treating the resin with 20% piperidine in DMF for 10 min. Manual couplings were monitored using the TNBS (trinitrobenzene sulfonate) test.
4
The resin cleavage-deprotection was accomplished by shaking the resin-bound peptides for 2 h (approx. 0.025 mmol), in 3 mL of the cleavage cocktail cleavage cocktail S (25 µL of EDT (1,2-ethanedithiol), 25 µL of H 2 O, 10 µL of TIS (triisopropylsilane) and 940 µL of TFA). The resin is filtered, and the TFA filtrate is added to ice-cold diethyl ether (30 mL). After 10 min, the precipitate is centrifuged and washed again with 20 mL of ice-cold ether. The solid residue is dried under argon, dissolved in acetonitrile/water 1:1 (2 mL) and purified by semipreparative RP-HPLC. The collected fractions are lyophilized and stored at −20 °C.
After lyophilization, the peptides were obtained as white powders. brC: 28.1 mg, 7.6 µmol, approx. 30% yield, and ebpC: 28.2 mg, 6.7 µmol, approx. 27%).
The synthesis of (brGGC) 2 SS and (brGGC)SH peptides has been previously reported. 
Synthesis of the ruthenium-peptide conjugates

Synthesis of Ru(brC) 2
The purified peptide brC (6 mg, approx. 1.6 µmol) and the ruthenium linker 2 (0.6 mg, 0.54 µmol) were dissolved in a mixture of deoxygenated 100 mM phosphate buffer, pH 7.8 (150 µL) and acetonitrile (20 µL). The resulting mixture was stirred for 1 h at rt and the crude purified by RP-HPLC. The combined HPLC fractions containing the product were freeze-dried to give the peptide conjugate as an orange powder (1.4 mg, 0.16 µmol, 30 %). 
ESI-MS [MH
Synthesis of Ru(ebpC)
The purified peptide ebpC (3 mg, approx. 0.72 µmol) was dissolved in a deoxygenated 100 mM phosphate buffer, pH 7.8 (150 µL). The ruthenium linker 2 (1.5 mg, 0.54 µmol) was dissolved in acetonitrile (20 µL) and then added to the ebpC solution. The mixture was stirred for 1 h at rt and the resulting crude purified by RP-HPLC. After lyophilization the product was obtained as an orange powder (0.72 mg, 0.14 µmol, 26 %). 
ESI-MS
Synthesis of Ru(brC)(ebpC)
The purified peptides Ru(ebpC) (1.2 mg, approx. 0.24 µmol) and brC (2.2 mg, approx. 0.6 µmol) were dissolved in a deoxygenated 100 mM phosphate buffer, pH 7.8 (200 µL). The mixture was stirred for 1 h at rt and the resulting crude purified by RP-HPLC. After lyophilization the product was obtained as an orange powder (3.1 mg, 0.36 µmol, approx. 60 %). 
Photolysis experiments
The photolysis experiments were carried out using a fluorescence microscope with a 12 V/100 W halogen bulb lamp, by irradiation through the 530-550 nm excitation filter (green channel).
A solution of Ru(brC) 2 (60 µM in milliQ water) was exposed to green light, after 30 min the sample was analyzed by HPLC-MS. A solution of Ru(brC)(ebpC) (10 μM in milliQ water) was exposed to green light, after 30 min the sample is analyzed by HPLC-MS. Figure S8 . 
Figure S10. Ion trace of the peak at the indicated retention time: left (brC-NH 2 ), right (brC-
Ru(bipy) 2 OH 2 ).
The photolysis can be carried much faster using a LED source at 455 nm (900 mW). In this way, the photolysis is completed in only 2 minutes as shown in figure S11 . This is in part a consequence of the maximum absorption for the bipyridine ruthenium complexes is about 460 nm. The resulting plasmid (pGL3-CRE-Luc) was used to test the possibility of base oxidation upon photoirradiation in the presence of Ru(II)-peptide complex. The experiment consisted on the incubation of 1 µM of Ru(brC) 2 with 27.6 µg/mL of the plasmid in 10 mM Na-cacodylate buffer pH 7.5, followed by irradiation of the mixture for 20 min with a long-wavelenght light source (530-550 nm). Then, the mixture was treated under standard conditions to detect oxidative damaged in plasmids (0.1 M piperidine at 65°C for 5 min) 7 and analysed by 1% agarose gel electrophoresis.
As shown in Figure S13 , the treatment doesn't generate new bands in the gel (lane 3), that there is not any oxidative damage during the photoirradiation, in contrast to that observed when the plasmid is treated with Fe +2 in the presence of oxygen (lane 4). 
Fluorescence Anisotropy
Measurements were made with a Jobin-Yvon Fluoromax-3, (DataMax 2.20) coupled to a Wavelength Electronics LFI−3751 temperature controller, using the following settings: integration time: 1.0 s; excitation slit width: 3.0 nm; emission slit width: 6.0 nm; excitation wavelength 559 nm; emission wavelength 585 nm.
TAMRA-ATF/CREB (TAMRA--5'-CGG ATGACGTCAT TTTTTTTC-3', one strand shown) 9 (5 µL, 5 µM) was added to 995 µL of Tris-HCl buffer 20 mM pH 7.5, 100 mM NaCl, and the anisotropy was measured. Aliquots of a stock solution in the same buffer of the dimer Ru(brC) 2 (12.5 µM) were successively added to this solution, and the anisotropic value was recorded after each addition. TAMRA-ATF/CREB (5 µL, 5 µM) was added to 995 µL of Tris-HCl buffer 20 mM pH 7.5, 100 mM NaCl, and calf thymus DNA (50 µM in base pairs), and the anisotropy was measured. Aliquots the stock solution of the dimer Ru(brC) 2 were successively added to this solution, and the anisotropic value was recorded after each addition. 
Circular Dichroism (CD)
Measurements were made with a Jasco-715 coupled with a thermostat Nestlab RTE-111. The settings used were: Acquisition range: 300-195nm; band width: 2.0 nm; resolution: 0.2 nm; accumulation: 2 scans; sensitivity 10 mdeg; response time: 0.25 s, speed: 100 nm/min. CD measurements were made in a 2 mm cell at 20ºC. Samples contained 5 µM of corresponding dsDNA (when present) and 5 µM of peptides in 10 mM phosphate buffer (pH 7.5) and 100 mM of NaCl. The CD spectra of the peptides (when measured in the presence of DNA) were calculated as the difference between the spectrum of the peptide/DNA mixture and the measured spectrum of a sample of the DNA oligonucleotide.
Control CD experiments
We have done comparative CD assays using Ru(brC) 2 , the disulphide dimer (brGGC) 2 SS and the monomer (brGGC)SH. Results are shown in figures S13 and S14. The observed helicity after the photolysis is consistent with the formation of monomeric peptides 
Quantum yield calculation
The quantum yield of photolysis of the linker (Φ unc ≈ 0.56) was obtained by comparing its photodegradation rate with that of [Ru(bpy) 2 PPh 3 -GABA] + . Isoabsorbant solutions of 1a and [Ru(bpy) 2 PPh 3 -GABA] + (Φ unc ≈ 0.2) 10 were simultaneously irradiated and aliquots of both solutions were HPLC-analyzed after specific irradiation times. Their normalized peak areas were plotted against the total irradiation time, and adjusted to a monoexponential decay to compare the rates of photolysis. 
UV spectra of 2
UV measurements were made in a Jasco V-630 spectrophotometer coupled to a Jasco ETC-717 temperature controller, using a standard Hellma semi-micro cuvette (140.002-QS). Measurements were made at 20 ºC. 
